APO Research

APO RESEARCH · REPORT

Gengnian An Tablets

Selected research

Market Outlook & Growth Opportunities

Global Gengnian An Tablets Market Outlook and Growth Opportunities 2026

Market perspective

The global Gengnian An Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gengnian An Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gengnian An Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gengnian An Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gengnian An Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gengnian An Tablets market include Yabao Pharmaceutical Group Co., Ltd., Xi'an Zili Chinese Medicine Group Co., Ltd., Shanxi Zhendong Pharmaceutical Co., Ltd., Lanzhou Taibao Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd., Tianjin Medicine Darentang Group Co., Ltd., Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd., Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. and Jiangxi Jimin Kexin Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gengnian An Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gengnian An Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gengnian An Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gengnian An Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Gengnian An Tablets Segment by Company

Yabao Pharmaceutical Group Co., Ltd.

Xi'an Zili Chinese Medicine Group Co., Ltd.

Shanxi Zhendong Pharmaceutical Co., Ltd.

Lanzhou Taibao Pharmaceutical Co., Ltd.

Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd.

Tianjin Medicine Darentang Group Co., Ltd.

Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd.

Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.

Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.

Jilin Zixin Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Guilong Pharmaceutical (Anhui) Co., Ltd.

Guangxi Jinhaitang Pharmaceutical Co., Ltd.

Gengnian An Tablets Segment by Type

Sugar-coated Tablets

Non-sugar-coated Tablets

Gengnian An Tablets Segment by Application

Hospital

Clinic

Other

Gengnian An Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gengnian An Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gengnian An Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gengnian An Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Gengnian An Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gengnian An Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gengnian An Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gengnian An Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gengnian An Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gengnian An Tablets industry.

Chapter 3: Detailed analysis of Gengnian An Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gengnian An Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gengnian An Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gengnian An Tablets Industry Trends Table 2. Gengnian An Tablets Industry Drivers Table 3. Gengnian An Tablets Industry Opportunities and Challenges Table 4. Gengnian An Tablets Industry Restraints Table 5. Global Gengnian An Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gengnian An Tablets Revenue Share by Company (2021-2026) Table 7. Global Gengnian An Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gengnian An Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Gengnian An Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gengnian An Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gengnian An Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Gengnian An Tablets Company, Product Type & Application Table 13. Global Gengnian An Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gengnian An Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sugar-coated Tablets Table 18. Significant Companies of Non-sugar-coated Tablets Table 19. Global Gengnian An Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gengnian An Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Gengnian An Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Gengnian An Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Gengnian An Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Gengnian An Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gengnian An Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gengnian An Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gengnian An Tablets Sales Value Share by Type (2021-2026) Table 28. Global Gengnian An Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Gengnian An Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Gengnian An Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Gengnian An Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Gengnian An Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Gengnian An Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Gengnian An Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Gengnian An Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Gengnian An Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Gengnian An Tablets Sales Value Share by Application (2021-2026) Table 41. Global Gengnian An Tablets Sales Value Share by Application (2027-2032) Table 42. Global Gengnian An Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Gengnian An Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Gengnian An Tablets Sales Market Share by Region (2021-2026) Table 45. Global Gengnian An Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Gengnian An Tablets Sales Market Share by Region (2027-2032) Table 47. Global Gengnian An Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gengnian An Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Gengnian An Tablets Sales Value Share by Region (2021-2026) Table 50. Global Gengnian An Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Gengnian An Tablets Sales Value Share by Region (2027-2032) Table 52. Global Gengnian An Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Gengnian An Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Gengnian An Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Gengnian An Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Gengnian An Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Gengnian An Tablets Sales Market Share by Country (2021-2026) Table 58. Global Gengnian An Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Gengnian An Tablets Sales Market Share by Country (2027-2032) Table 60. Global Gengnian An Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Gengnian An Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Gengnian An Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Gengnian An Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yabao Pharmaceutical Group Co., Ltd. Company Information Table 65. Yabao Pharmaceutical Group Co., Ltd. Business Overview Table 66. Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Product Portfolio Table 68. Yabao Pharmaceutical Group Co., Ltd. Recent Development Table 69. Xi'an Zili Chinese Medicine Group Co., Ltd. Company Information Table 70. Xi'an Zili Chinese Medicine Group Co., Ltd. Business Overview Table 71. Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Product Portfolio Table 73. Xi'an Zili Chinese Medicine Group Co., Ltd. Recent Development Table 74. Shanxi Zhendong Pharmaceutical Co., Ltd. Company Information Table 75. Shanxi Zhendong Pharmaceutical Co., Ltd. Business Overview Table 76. Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 78. Shanxi Zhendong Pharmaceutical Co., Ltd. Recent Development Table 79. Lanzhou Taibao Pharmaceutical Co., Ltd. Company Information Table 80. Lanzhou Taibao Pharmaceutical Co., Ltd. Business Overview Table 81. Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 83. Lanzhou Taibao Pharmaceutical Co., Ltd. Recent Development Table 84. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Company Information Table 85. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Business Overview Table 86. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Product Portfolio Table 88. Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Recent Development Table 89. Tianjin Medicine Darentang Group Co., Ltd. Company Information Table 90. Tianjin Medicine Darentang Group Co., Ltd. Business Overview Table 91. Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Product Portfolio Table 93. Tianjin Medicine Darentang Group Co., Ltd. Recent Development Table 94. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Company Information Table 95. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Business Overview Table 96. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 98. Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Recent Development Table 99. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information Table 100. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview Table 101. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 103. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Development Table 104. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information Table 105. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview Table 106. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 108. Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Development Table 109. Jilin Zixin Pharmaceutical Co., Ltd. Company Information Table 110. Jilin Zixin Pharmaceutical Co., Ltd. Business Overview Table 111. Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 113. Jilin Zixin Pharmaceutical Co., Ltd. Recent Development Table 114. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 115. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 116. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 118. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 119. Guilong Pharmaceutical (Anhui) Co., Ltd. Company Information Table 120. Guilong Pharmaceutical (Anhui) Co., Ltd. Business Overview Table 121. Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Product Portfolio Table 123. Guilong Pharmaceutical (Anhui) Co., Ltd. Recent Development Table 124. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Company Information Table 125. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Business Overview Table 126. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio Table 128. Guangxi Jinhaitang Pharmaceutical Co., Ltd. Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Gengnian An Tablets Distributors List Table 132. Gengnian An Tablets Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Gengnian An Tablets Product Image Figure 2. Global Gengnian An Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gengnian An Tablets Sales (2021-2032) & (K Units) Figure 5. Global Gengnian An Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gengnian An Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sugar-coated Tablets Image Figure 10. Non-sugar-coated Tablets Image Figure 11. Global Gengnian An Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Gengnian An Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gengnian An Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Gengnian An Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gengnian An Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gengnian An Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Gengnian An Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Gengnian An Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Gengnian An Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Gengnian An Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Gengnian An Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Gengnian An Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Gengnian An Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Gengnian An Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Gengnian An Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Gengnian An Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Gengnian An Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Gengnian An Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Gengnian An Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Gengnian An Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Gengnian An Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Gengnian An Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Gengnian An Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Gengnian An Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Gengnian An Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Sugar-coated Tablets
  • Non-sugar-coated Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yabao Pharmaceutical Group Co., Ltd.
  • Xi'an Zili Chinese Medicine Group Co., Ltd.
  • Shanxi Zhendong Pharmaceutical Co., Ltd.
  • Lanzhou Taibao Pharmaceutical Co., Ltd.
  • Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd.
  • Tianjin Medicine Darentang Group Co., Ltd.
  • Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd.
  • Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  • Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Guilong Pharmaceutical (Anhui) Co., Ltd.
  • Guangxi Jinhaitang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gengnian An Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Gengnian An Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Gengnian An Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gengnian An Tablets Market Dynamics
  1. 2.1 Gengnian An Tablets Industry Trends
  2. 2.2 Gengnian An Tablets Industry Drivers
  3. 2.3 Gengnian An Tablets Industry Opportunities and Challenges
  4. 2.4 Gengnian An Tablets Industry Restraints
3 Gengnian An Tablets Market by Company
  1. 3.1 Global Gengnian An Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Gengnian An Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Gengnian An Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Gengnian An Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Gengnian An Tablets Company Ranking (2024-2026)
  6. 3.6 Global Gengnian An Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Gengnian An Tablets Company Product Type and Application
  8. 3.8 Global Gengnian An Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gengnian An Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gengnian An Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gengnian An Tablets Market by Type
  1. 4.1 Gengnian An Tablets Type Introduction
  2. 4.1.1 Sugar-coated Tablets
  3. 4.1.2 Non-sugar-coated Tablets
  4. 4.2 Global Gengnian An Tablets Sales Volume by Type
  5. 4.2.1 Global Gengnian An Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gengnian An Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gengnian An Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gengnian An Tablets Sales Value by Type
  9. 4.3.1 Global Gengnian An Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gengnian An Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gengnian An Tablets Sales Value Share by Type (2021-2032)
5 Gengnian An Tablets Market by Application
  1. 5.1 Gengnian An Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Gengnian An Tablets Sales Volume by Application
  6. 5.2.1 Global Gengnian An Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gengnian An Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gengnian An Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gengnian An Tablets Sales Value by Application
  10. 5.3.1 Global Gengnian An Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gengnian An Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gengnian An Tablets Sales Value Share by Application (2021-2032)
6 Gengnian An Tablets Regional Sales and Value Analysis
  1. 6.1 Global Gengnian An Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gengnian An Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Gengnian An Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Gengnian An Tablets Sales by Region (2027-2032)
  5. 6.3 Global Gengnian An Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gengnian An Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gengnian An Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gengnian An Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Gengnian An Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gengnian An Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Gengnian An Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gengnian An Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Gengnian An Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gengnian An Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gengnian An Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gengnian An Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Gengnian An Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gengnian An Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gengnian An Tablets Sales Value Share by Country, 2025 VS 2032
7 Gengnian An Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Gengnian An Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gengnian An Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gengnian An Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Gengnian An Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Gengnian An Tablets Sales by Country (2027-2032)
  6. 7.4 Global Gengnian An Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gengnian An Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gengnian An Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gengnian An Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gengnian An Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gengnian An Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yabao Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Yabao Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yabao Pharmaceutical Group Co., Ltd. Gengnian An Tablets Product Portfolio
  6. 8.1.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Xi'an Zili Chinese Medicine Group Co., Ltd.
  8. 8.2.1 Xi'an Zili Chinese Medicine Group Co., Ltd. Company Information
  9. 8.2.2 Xi'an Zili Chinese Medicine Group Co., Ltd. Business Overview
  10. 8.2.3 Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Zili Chinese Medicine Group Co., Ltd. Gengnian An Tablets Product Portfolio
  12. 8.2.5 Xi'an Zili Chinese Medicine Group Co., Ltd. Recent Developments
  13. 8.3 Shanxi Zhendong Pharmaceutical Co., Ltd.
  14. 8.3.1 Shanxi Zhendong Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Shanxi Zhendong Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanxi Zhendong Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  18. 8.3.5 Shanxi Zhendong Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Lanzhou Taibao Pharmaceutical Co., Ltd.
  20. 8.4.1 Lanzhou Taibao Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Lanzhou Taibao Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lanzhou Taibao Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  24. 8.4.5 Lanzhou Taibao Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd.
  26. 8.5.1 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Company Information
  27. 8.5.2 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Business Overview
  28. 8.5.3 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Gengnian An Tablets Product Portfolio
  30. 8.5.5 Sunflower Pharmaceutical Group (Jiamusi) Co., Ltd. Recent Developments
  31. 8.6 Tianjin Medicine Darentang Group Co., Ltd.
  32. 8.6.1 Tianjin Medicine Darentang Group Co., Ltd. Company Information
  33. 8.6.2 Tianjin Medicine Darentang Group Co., Ltd. Business Overview
  34. 8.6.3 Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tianjin Medicine Darentang Group Co., Ltd. Gengnian An Tablets Product Portfolio
  36. 8.6.5 Tianjin Medicine Darentang Group Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  42. 8.7.5 Jiangxi Nanchang Sanghai Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  44. 8.8.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  48. 8.8.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
  50. 8.9.1 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  54. 8.9.5 Jiangxi Jimin Kexin Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin Zixin Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Zixin Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  60. 8.10.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  62. 8.11.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  66. 8.11.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Guilong Pharmaceutical (Anhui) Co., Ltd.
  68. 8.12.1 Guilong Pharmaceutical (Anhui) Co., Ltd. Company Information
  69. 8.12.2 Guilong Pharmaceutical (Anhui) Co., Ltd. Business Overview
  70. 8.12.3 Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Guilong Pharmaceutical (Anhui) Co., Ltd. Gengnian An Tablets Product Portfolio
  72. 8.12.5 Guilong Pharmaceutical (Anhui) Co., Ltd. Recent Developments
  73. 8.13 Guangxi Jinhaitang Pharmaceutical Co., Ltd.
  74. 8.13.1 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Gengnian An Tablets Product Portfolio
  78. 8.13.5 Guangxi Jinhaitang Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gengnian An Tablets Value Chain Analysis
  2. 9.1.1 Gengnian An Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gengnian An Tablets Sales Mode & Process
  6. 9.2 Gengnian An Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gengnian An Tablets Distributors
  9. 9.2.3 Gengnian An Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research